AB0938 SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES.

D. Poddubnyy, L. S. Gensler, P. J. Mease, A. M. Orbai, R. B. Warren, B. Ink, U. Massow, D. Assudani, C. Fleurinck, V. Shende, J. Smith, L. Peterson, K. White, R. B. M. Landewé. AB0938 SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES. Annals of the Rheumatic Diseases. 2023 May 30; 82(Suppl 1):1686-1687.

2023
https://researcherprofiles.org/profile/425025910

D. Poddubnyy, L. S. Gensler, P. J. Mease, A. M. Orbai, R. B. Warren, B. Ink, U. Massow, D. Assudani, C. Fleurinck, V. Shende, J. Smith, L. Peterson, K. White, R. B. M. Landewé